• Latest Posts
Expert Advice 27 May 2020

Why Listening to Patient Organizations is Key in Drug Development

Argenx’s Rare Disease Treatment Strikes Gold in Phase III

In Depth 25 May 2020

Could Cell Therapy Target the Symptoms of Severe Covid-19?

Evonik and Beiersdorf Team Up to Turn CO₂ into Skin Care Products

Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease

Interview 21 May 2020

What 2019 Can Teach About European Biotech Investments Going Forward

ADVERTISEMENT

Phase II Success for Once-a-Day Eye Drops after Cataract Surgery

Antibacterial Eliminates Recurrence of C. Difficile Infections in Phase II

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

Update: Spanish Food Startup Raises €12M to Grow Healthier Animal Fats

Affibody Signs €208M Deal To Market Autoimmune Drug in China

ADVERTISEMENT